Johnson & Johnson's diabetes care unit to exit insulin pump business

(Reuters) - Animas Corp, Johnson & Johnson's diabetes care unit, said it intends to exit the insulin pump business and has selected Medtronic Plc as its partner for patients on insulin pumps.